Enceladus Pharmaceuticals BV - Company Review
Enceladus Pharmaceuticals BV - Company ReviewSummary
Enceladus Pharmaceuticals BV (Enceladus) is a healthcare products provider that develops liposomal formulations. The company offers nanocort, a novel pharmaceutical drug composed of corticosteroids enclosed in small lipid vesicles that after intravenous injection selectively accumulate in inflamed tissues and in tumors. Its other products comprise oncocort, a liposomal dexamethasone for the treatment of prostate carcinoma and metastasized multiple myeloma; and innovicort for severe skin, eye, and mucosal tissue inflammation diseases. The company operates in collaboration with larger pharmaceutical companies for late stage development and marketing. It operates in the field of autoimmune diseases, inflammation, and cancer that are chronic, progressive, and debilitating. Enceladus is headquartered in Naarden, the Netherlands.
This comprehensive company report of Enceladus Pharmaceuticals BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.